American Portfolios Advisors Galapagos Nv Transaction History

American Portfolios Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Mar 22, 2023	BUY	$76.15 - $111.94 $8,376 - $12,313	110 New	110 $8.48 Million
Q4 2020 Mar 22, 2023	BUY	$96.85 - $148.25 $9,975 - $15,269	103 New	103 $10.2 Million
Q3 2020 Mar 22, 2023	BUY	$122.47 - $213.56 $12,614 - $21,996	103 New	103 $14.6 Million
Q1 2020 Mar 24, 2023	BUY	$143.0 - $274.03 $4,719 - $9,042	33 New	33 $6.47 Million
Q4 2019 Mar 24, 2023	BUY	$146.12 - $215.82 $5,260 - $7,769	36 New	36 $7.45 Million
Q3 2019 Mar 24, 2023	BUY	$130.44 - $187.64 $4,695 - $6,755	36 New	36 $5.5 Million
Q4 2017 Mar 24, 2023	BUY	$84.48 - $104.02 $422 - $520	5	5 $469,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.